<DOC>
	<DOCNO>NCT02194868</DOCNO>
	<brief_summary>The purpose study confirm invariant NKT lymphocyte ( iNKT ) reconstitution recipient graft content predict outcome human allogeneic HSCT set algorithm clinical practice would allow prediction acute GVHD risk accord quantity functionality</brief_summary>
	<brief_title>Immunoregulatory T Lymphocytes Subtypes Haematopoietic Stem Cell Transplantation ( HSCT )</brief_title>
	<detailed_description>Allogeneic hematopoietic stem cell transplantation ( HSCT ) remain curative treatment haematological malignancy . However , anti-tumor effect ( GVT ) often associate development graft versus host disease ( GVHD ) impair immune anti-infectious response . The predictive protective feature iNKT cell development acute GVHD ( aGVHD ) poorly know human mechanisms action , particular potential interaction regulatory effector immune actor allogeneic response , remain explored . Our project aim , first , show post-transplant reconstitution and/or content graft immunoregulatory T lymphocytes early predict post-transplant clinical outcome , second , explore underlying immunological mechanism . For , propose analyse , homogeneous cohort allografted patient donor , level iNKT cell cell population implicate allogeneic immune response ( Tregs , mucosa-associated invariant T ( MAIT ) cell , delta gammaT anti-viral specific T cell ) correlate result post-transplant outcome ( GVHD , infection , relapse , survival ) . This study perform cohort 80 adult allografted patient four transplant department Paris ( hospital Necker , Saint Antoine , Saint Louis La Pitié Salpétrière ) cohort 60 allografted paediatric patient ( Robert Debré hospital Paris ) . Sequential blood sample patient draw monitor immune reconstitution different lymphocyte population interest flow cytometry perform functional study iNKT ( ex vivo expansion capacity cytokine production ) . These analysis also perform corresponding donor blood sample collect collection process graft ( obtain cell therapy department Necker , La Pitié Salpétrière Saint Louis hospital ) . In addition , plan analyse effect , mechanism , human CD4- CD4+ iNKT cell might control allogeneic response vitro , particularly via potential interaction dendritic cell Tregs . According result mechanistic study , test effect human subtypes iNKT cell GVH/GVL affect preclinical humanize mouse model allogeneic HSCT . The clinical biological data anonymously enter electronic case report investigator 3 year post transplant .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>1 . Criteria adult : Allogeneic HSCT PBSC graft Patients transplant cytologic Complete Remission ( CR ) HLA 10/10 HLA A , B , Cw , DRB1 DQ molecule , intrafamilial unrelated donor FludarabineivBusulfanATG base reduce intensity/toxicity conditioning . Iv Busulfan dose 6.4 mg/kg 9.6 mg/kg accept . ATG thymoglobulin 5 mg/kg . Consent form sign patient Consent form sign donor Affiliated beneficiary health insurance regimen 2 . Criteria pediatric patient : Allogeneic HSCT bone marrow graft Myeloablative conditioning ( either TBI 12 Gy Cyclophosphamide iv Busulfan ( 12.8 mg/kg ) cyclophosphamide ) HLA 10/10 HLA A , B , Cw , DRB1 DQ molecule , intrafamilial unrelated donor Consent form sign parent Consent form sign donor legal representative minor Beneficiary health insurance regimen History previous autologous allogeneic haematopoietic stem cell transplantation Disease non cytologic CR transplant Other type condition FludarabineivBusulfanATG base reduced intensity/toxicity . Donor graft HLA mismatch include haploidentical cord blood graft Graft one mismatch recipient HLA</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Allogeneic hematopoietic stem cell transplantation ,</keyword>
	<keyword>Immunoregulatory T lymphocytes ,</keyword>
	<keyword>acute graft versus host disease</keyword>
</DOC>